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Abstract
Fatigue is a common and debilitating symptom, affecting 42–89% of end-stage kidney disease patients, persisting even in
pre–dialysis care and stable kidney transplantation, with huge repercussions on functioning, quality of life and patient out-
comes. This paper presents a critical review of current evidence for the role of psychological factors in renal fatigue. To
date, research has concentrated primarily on the contribution of depression, anxiety and subjective sleep quality to the
experience of fatigue. These factors display consistent and strong associations with fatigue, above and beyond the role of
demographic and clinical factors. Considerably less research is available on other psychological factors, such as social sup-
port, stress, self-efficacy, illness and fatigue-specific beliefs and behaviours, and among transplant recipients and patients
in pre-dialysis care. Promising evidence is available on the contribution of illness beliefs and behaviours to the experience
of fatigue and there is some indication that these factors may vary according to treatment modality, reflecting the differen-
tial burdens and coping necessities associated with each treatment modality. However, the use of generic fatigue scales
casts doubt on what specifically is being measured among dialysis patients, illness-related fatigue or post-dialysis-specific
fatigue. Therefore, it is important to corroborate the available evidence and further explore, qualitatively and quantitatively,
the differences in fatigues and fatigue-specific beliefs and behaviours according to renal replacement therapy, to ensure
that any model and subsequent intervention is relevant and grounded in the experiences of patients.
Key words: anxiety, depression, fatigue, kidney disease, sleep quality
Introduction
Fatigue is a complex array of symptoms that has been described
as ‘extreme and persistent tiredness, weakness or exhaustion-
mental, physical, or both’ [1–3]. It has consistently emerged as a
common and debilitating symptom across chronic conditions
[4–7]. Likewise, fatigue is a common complaint in end-stage kid-
ney disease (ESKD), affecting from 42% to 89% of patients, and is
present across the full spectrum of chronic kidney disease
(CKD), affecting patients not yet requiring renal support, to
patients on dialysis, and persisting in patients who have subse-
quently received a renal transplant [3, 8].
In ESKD, fatigue has huge repercussions on functioning and
quality of life, further impairing patients’ daily functioning, moti-
vation and social engagement [9–14], and contributing to poorer
sleep quality and increased bodily pain [13–17]; however, these
associations are likely to be bidirectional. Above all, there is also
evidence to suggest that fatigue may contribute directly to clinical
outcomes, increasing the risk of cardiac events [18] and mortality
Received: August 4, 2016. Accepted: September 28, 2016
VC The Author 2016. Published by Oxford University Press on behalf of ERA-EDTA.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
For commercial re-use, please contact journals.permissions@oup.com
79
Clinical Kidney Journal, 2017, vol. 10, no. 1, 79–88
doi: 10.1093/ckj/sfw113
Advance Access Publication Date: 20 December 2016
CKJ review
[19]. Given the significance of fatigue and its consequences on
patient outcomes and quality of life, timely and effective manage-
ment of fatigue represents a clinical priority. Currently, no consis-
tent and theory-led treatment model of fatigue exists, with
management relying primarily on pharmacological treatments
targeting anaemia or involving patients in exercise [3]. A review of
pharmacological treatments for fatigue among dialysis patients
reached the conclusion that no medications can be recommended
for the prevention of fatigue, and complete and prolonged relief
from fatigue is rare [8]. Exercise-based interventions, on the other
hand, have been criticized for being unsuitable for patients with
multi-morbidities, disabilities and in poorer health [20].
To date, a number of reviews have attempted to synthesize
the available research on the factors associated with fatigue in
this patient population [3, 8, 21, 22]. These reviews provided
interesting insights on the prevalence of renal fatigue [3, 8], the
type of fatigue measurements relied upon [3, 8, 22] and the out-
comes associated with fatigue [3, 8, 22]. Overall, these reviews
unanimously indicate that the findings are often mixed and
inconclusive, with little success in identifying demographic,
social-situational and clinical factors that are consistently asso-
ciated with the experience of fatigue.
These reviews concentrated mainly on dialysis patients and
did not differentiate between studies reporting fatigue versus
vitality outcomes [3, 8, 21, 22]. The concept of vitality is consid-
ered to be at the opposite end to fatigue on a fatigue–vitality con-
tinuum [3]. Some debate exists on the comprehensiveness of the
concept of vitality, capturing a reduction in energy levels, but not
necessarily the negative aspects of fatigue, such as weakness,
lack of motivation and difficulty with concentration [22]. Given
that the vitality subscale of the SF-36 is the most widely used
instrument in the dialysis population as a marker of fatigue [23,
24], it is important to assess whether systematic differences exist
in factors associated with fatigue versus vitality.
Overall, the evidence for the role of demographic and social-
situational factors in the experience of fatigue is mostly weak
and inconsistent (e.g. [25–34]). Similarly, in relation to clinical
factors, there is generally a lack of evidence for the significant
variation in fatigue according to dialysis adequacy, serum albu-
min, haemoglobin or other clinical factors [e.g. 27, 29, 33, 35].
This may be due to the relative homogeneity of clinical values,
maintained within the recommended ranges across many stud-
ies [3, 8]. However, indisputably, poorly managed patients are
likely to report worse outcomes and exacerbated symptoms,
including fatigue [e.g. 36–40]. Findings are generally in agree-
ment on the negative impact of physical inactivity [31–33, 41]
and comorbidities on fatigue [28, 29, 33, 35, 42]. A greater num-
ber of concomitant conditions may lead to worse overall health
and functioning, and increased stress and burden imposed by
additional treatment requirements [3]. While, poor physical
functioning may contribute to fatigue, fatigue may also lead to
inability to engage in activities; therefore, the direction of this
association is unclear given the prevalence of cross-sectional
research [8].
To our knowledge, this is the first narrative review providing a
more comprehensive and in-depth overview of the role of psycho-
logical and cognitive-behavioural factors in the experience of
fatigue in the renal population. Also, differences in factors associ-
ated with fatigue as compared with vitality and variations by renal
replacement therapy (RRT) were explored. In order to develop
theory-based and effective interventions for fatigue in ESKD, it is
important to identify potentially modifiable factors that contribute
to fatigue above and beyond the influence of demographic, social-
situational and clinical factors, in each treatment modality.
Review questions
(i) What is the available evidence for the role of psychological
and cognitive behavioural factors in ESKD fatigue?
(ii) Are there any differences in factors depending on outcome
used: fatigue versus vitality?
(iii) Are there any differences in factors associated with fatigue/
vitality depending on the type of RRT?
Materials and methods
Search
In anticipation of a large volume of research examining the associ-
ation between depression, anxiety, subjective sleep quality and
fatigue, a narrative review approach was selected to synthesize
the evidence on the aforementioned factors and capture what
other psychological factors have been explored to date. This narra-
tive review was guided by principles and methods of a systematic
review. To identify relevant articles, the following databases were
searched: (i) Embase (via Ovid), (ii) Medline (via Ovid), (iii) PsycInfo
(via Ovid), (iv) Global Health (via Ovid) and (v) Web of Science. A
combination of ESKD and fatigue terms was used (please see Box
1, in Supplementary Appendix A). The search strategy was
adapted to each database. Alongside the electronic search, a man-
ual search was also conducted to identify any additional articles.
The search was limited to full-text articles to allow for adequate
appraisal of the findings (Table 1). The studies were included if the
sample consisted of adult (aged 18 years or older) ESKD patients,
with their glomerular filtration rate (GFR) falling below 60 mL/
min/1.73 m2, regardless of the RRT they were receiving or if they
were in pre-dialysis care. Only articles that measured fatigue or
vitality and reported explicit findings related to potential predic-
tors of fatigue/vitality, measured by independent instruments,
and not within-scale correlations, were included in this review.
Psychological factors were defined as cognitive, emotional or
behavioural factors typically considered modifiable in the context
of psychosocial interventions. Intervention studies, studies
assessing the consequences of fatigue on functioning, mortality or
quality of life, or articles that included a fatigue subscale but failed
to report discernible fatigue findings were excluded. Please see
Supplementary Appendix B for further information.
Quality assessment
All identified studies underwent a quality assessment using a
modified version of the Effective Public Health Practice Project
(EPHPP) quality assessment tool that covers any quantitative study
design to provide a descriptive overview of the quality of the current
evidence base. Overall quality scores for each study were not com-
puted. Relevant considerations appropriate to the studies were
added to the assessment list, in particular: what study design was
used, whether a power calculation was reported, what type of
recruitment was used, what percentage of selected individuals
agreed to participate, whether participants could be deemed repre-
sentative of the population, whether reliable and valid instruments
were used, whether analyses were appropriate, whether the P-value
was adjusted for multiple analyses and whether confidence inter-
vals were reported (where appropriate). A full description of the rat-
ings for each study can be found in Supplementary Appendix C.
Analysis
Data from the included studies were extracted using a data
extraction form that was adapted from the data collection
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checklist by the Cochrane Effective Practice and Organisation of
Care Review Group to suit the purpose of this review. Key
aspects of data extraction included: patient demographics, clini-
cal and illness-related information, fatigue instrument used,
investigated psychological factors, data analyses, and results
for the associations between the investigated psychological fac-
tors and fatigue as an outcome. A narrative synthesis was con-
ducted to provide a textual summary of the findings, pertaining
to the reported associations between psychological factors and
fatigue as an outcome, across all the included studies, and to
identify any difference according to treatment modality and
fatigue measurement used [74].
Results
Fifty-four studies were identified that reported on the associa-
tion between psychological variables and fatigue, mainly within
investigations of the predictors of quality of life in this setting,
rather than fatigue-specific studies. The vast majority of these
studies were cross-sectional (N ¼ 46), relying on single-centre
recruitment (N ¼ 35). Sample sizes ranged from 33 [74] to 1798
[16]. On the whole, there was a lack of consideration of power
across the studies. Similarly, in most studies (N ¼ 52) alpha
was not adjusted for multiple analyses. There was great varia-
bility in inclusion and exclusion criteria from study to study,
especially evident with regards to dialysis vintage (see
Supplementary Appendix C). Samples varied considerably,
owing to the differences in research aims, participant selection
criteria and RRT from study to study (see Supplementary
Appendix C). Forty-three studies were exclusive to dialysis
patients, with four studies consisting of mixed samples of both
dialysis patients and transplant recipients. Only four studies
included solely transplant recipients, and one study followed
patients from pre-transplantation to post-transplantation.
None of the studies consisted exclusively of patients in pre-
dialysis care, but two studies included patients not undergoing
dialysis alongside dialysis patients. Although there was varia-
tion in the instruments used, predominantly studies relied on
established and validated instruments. Analyses were in gen-
eral appropriate given the different research aims across the
studies (see Supplementary Appendix C).
Psychological and cognitive behavioural factors
To date, attention has been predominantly paid to depression,
anxiety and subjective sleep quality with regard to fatigue,
mainly among dialysis patients (N ¼ 44; see Table 1). From
here onwards, studies from Table 1 are referred to using their
assigned reference numbers. Limited research is available
regarding other psychological and cognitive constructs that
have been previously implicated in fatigue in other chronic ill-
nesses [75–78].
Depression and anxiety. Depression and fatigue overlap signifi-
cantly in how they are experienced, and depression often mani-
fests itself in lethargy and a feeling of weakness and tiredness
in the general population, as well as in patient populations [8,
79–83]. Therefore, drawing conclusive interpretations as to the
causality of this association is not possible [3]. Thirty-eight
studies were identified that looked at the relationship between
depression and fatigue/vitality. The majority (N ¼ 36) found a
consistent significant association between the two, with
depressed patients reporting greater levels of fatigue and lower
vitality (study numbers 1–10, 12–16, 18–22, 24, 26–29, 31–32,
34–38, 40–42, 44 in Table 1).
There is also evidence to suggest a significant association
between anxiety and fatigue among dialysis patients and
transplant recipients, where out of 18 studies reporting on this
association, 15 found a significant positive association
between the two (study numbers 2, 3, 6, 8–10, 14, 16, 30, 31,
35, 38, 40, 42, 44 in Table 1). Overall, some studies found
that depression and other mood disorders can explain up to
38–46% of the variance in fatigue (study numbers 27, 44 in
Table 1).
Only a small minority of studies failed to corroborate the
association between depression, anxiety and fatigue. This may
be explained by sample differences, where Letchmi et al. (2011)’s
study (study number 25 in Table 1) was conducted in Malaysia
and the lack of association between these factors may be
explained by cultural differences and stigma associated with
psychological distress in Asian cultures [84, 85]. In fact, the
prevalence of anxiety and depression was low in Letchmi et al.’s
sample (study numbers 25 in Table 1). Any inconsistent find-
ings may also be explained by the great variability in the meas-
urement of fatigue, depression and anxiety, the likely reason for
the disparity in DePasquale et al. ’s study (study number 11 in
Table 1).
Subjective sleep quality. Even though the evidence for the role of
objective sleep parameters, such as total sleep duration (e.g.
study number 35 in Table 1) in the experience of fatigue seems
to be weak, 13 studies were identified that examined the associ-
ation between subjective sleep quality and fatigue. There was
unanimous agreement with regards to the significant associa-
tion between poorer subjective sleep quality and greater fatigue
and lower vitality (study numbers 2, 8, 15–19, 23, 31, 33, 39, 42–
43 in Table 1). Only one study failed to find a significant associa-
tion between self-reported daytime sleepiness and vitality
among peritoneal dialysis patients [86], whereas two studies
were in support of this association [35, 54]. The prevalence of
daytime sleepiness was low and the presence of restless leg
syndrome (RLS), sleep apnoea and other sleep-disturbing fac-
tors were selected as exclusion criteria in the former study [86].
Social support. The relationship between social support and
fatigue in renal patients has not been studied extensively [3, 21].
Out of 11 studies identified here, 7 found that severely fatigued
renal patients perceive lower social support from friends and
family [32, 72, 87–90]; this was further elaborated by Akin et al.
(2014) [25] reporting that as levels of loneliness and fatigue
increased, self-care abilities decreased, suggesting that greater
fatigue severity and lower social support can have a detrimental
influence on functioning and wellbeing. However, other studies
did not find a significant association between social support
and fatigue/vitality in the renal patient population [28, 40, 66,
73]. Great variability was evident in the measurement of social
support, from studies using different self-report social support-
specific scales [32, 40, 62, 66, 72, 73, 87] or social support scores
extrapolated from other instruments, like the Health-Promoting
Lifestyle Profile scale [88]. Given the mixed and limited evidence
pool, drawing any conclusions is premature, as any differences
can be also confounded by other factors, such as cultural differ-
ences and marital status.
Cognitive behavioural factors. Illness and symptom perceptions
and associated behaviours have often emerged as dominant
constructs in adjustment, quality of life and outcomes across
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chronic conditions [90, 91]. Illness perceptions refer to organ-
ized beliefs about a particular condition, which can then deter-
mine coping behaviours [92, 93]. Illness perceptions consist of
five dominant dimensions: (i) identity (how symptoms are
experienced and attributed to the illness); (ii) cause (beliefs
about causes of the illness); (iii) timeline (beliefs about the dura-
tion of the illness, cyclical, acute or chronic); (iv) consequences
(beliefs about the impact of the illness); and (v) control/cure
(beliefs regarding the controllability/curability of the illness)
[92, 93]. The contribution of illness perceptions and coping
behaviours to the experience of fatigue has been extensively
documented in the literature across a range of chronic condi-
tions (e.g. study numbers [75, 94] in Table 1). However, these
factors have been so far overlooked in ESKD. Two studies exam-
ined the contribution of beliefs about the illness to fatigue;
holding a severe illness identity and greater consequence
beliefs were associated with lower levels of vitality in a hier-
archical regression model, but none of the other illness
beliefs—timeline, personal control, illness coherence, and emo-
tional representations—emerged as significant with regards to
vitality [27]. The second study examined appraisals of the ill-
ness among haemodialysis (HD) and continuous ambulatory
peritoneal dialysis (CAPD) patients. Only the appraisal of the ill-
ness as a threat was significantly correlated with greater fatigue
in CAPD, whereas appraisal of the illness neither as a loss nor
as a challenge were associated with fatigue [95].
No research is currently available regarding fatigue-specific
beliefs and behaviours in this patient population. A prospective
study, led by the authors, is currently underway, evaluating
fatigue severity and fatigue-related functional impairment over
time and assessing what fatigue beliefs and behaviours, alongside
demographic and clinical variables, contribute to fatigue over
time. The baseline cross-sectional data from this study revealed
that an overall negative perception of fatigue, all-or-nothing and
avoidance/resting behaviours in response to fatigue were signifi-
cant predictors of greater fatigue severity, above and beyond the
role of demographic and clinical factors, as well as distress [33].
Other psychological factors. Six studies have explored additional
psychological factors in relation to fatigue/vitality. There is evi-
dence in support of the negative influence of worrying and stress
on energy levels [14, 88, 96]. One study also reported a significant
association between self-efficacy and decreased fatigue [96] and
illness intrusiveness and greater fatigue [97]. Additionally, there
is some indication that greater perception of health responsibility
and health–promoting behaviours can contribute to higher levels
of energy in transplant recipients [88].
An interesting insight emerged from Sayin et al. ’s study [28],
demonstrating a link between illness knowledge and energy
levels, where poorer illness knowledge was associated with
lower vitality. Support for this link was evident in a trial, where
following an educational intervention, illness knowledge
became significantly associated with lower fatigue; however, no
association between the two was evident at baseline [98].
A recent study indicated that subjective perception of exer-
tion following exercise was the only independent predictor of
physical fatigue in transplant (Tx) recipients, irrespective of
objective parameters of physical fitness [99].
The role of fatigue measurement
Across the literature, the evidence for the role of psychological
factors in fatigue seems to be generally consistent regardless of
instruments used. In particular, studies that used the vitality
Fig. 1. Preliminary biopsychosocial model of fatigue in end-stage kidney disease. This figure illustrates how fatigue can be triggered by illness, biochemical imbalances,
or stress and worrying, and it can then be perpetuated and maintained by a vicious cycle of negative beliefs, depression and/or anxiety and maladaptive behavioural
patterns. 1Grey boxes with arrows exemplify potential areas for intervention. Clinical management revolves around illness control and maintaining biochemical values
within optimal ranges, as well as management of comorbidities. Cognitive techniques can be used to identify and change negative beliefs (e.g. catastrophizing) and to
reduce depression and anxiety. Behavioural strategies, as part of psychotherapy, or physiotherapy can support patients in developing a stable activity pattern, and
healthy sleep and dietary habits. 2All-or-nothing ¼ behaviour characterized by bursts of activity followed by rest. 3Physiological arousal ¼ in response to stress,
chronic activation of the central and autonomic nervous systems as well as the endocrine system. 4Deconditioning ¼ changes in body systems due to physical inactiv-
ity and disuses, such as loss in muscle strength and tone.
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sub-scale of the SF-36 reported comparable findings. In fact, high
correlations exist between fatigue and vitality [12, 35, 41], sup-
porting the use of vitality as a marker of fatigue. An interesting
finding emerged from one study, where only subscales of the
Multi-dimensional Fatigue Inventory, specifically general fatigue
and mental fatigue, were significantly associated with anxiety,
but there was no association between anxiety and fatigue meas-
ured by the vitality subscale of the SF-36 and visual analogue
scale [41]. Fatigue-specific instruments may capture a wider spec-
trum of manifestations of tiredness as compared with the vitality
subscale of the SF-36 or any single item scales. In fact, since the
vitality subscale consists of only four items, whether it can
adequately represent all the facets of fatigue is questionable
[100]. There is a lack of studies comparing directly the vitality
subscale of the SF-36 with fatigue-specific instruments to discern
whether subtle systematic differences exist in the instruments’
abilities to capture relationships between the experience of
fatigue and psychological predictors. Additionally, none of the
currently available fatigue instruments have been specifically
developed for renal fatigue. The qualitative experience of fatigue
may differ between different patient populations. Therefore, the
content of generic fatigue instruments may fail to capture the rel-
evant to renal patients’ fatigue-related experiences [101], in par-
ticular with regards to illness-related fatigue and post-dialysis-
specific fatigue experiences.
Discussion
The aim of this narrative review was to build on previous
reviews, by concentrating exclusively on the currently available
evidence on the role of psychological factors in renal fatigue,
across the full spectrum of ESKD. There was agreement between
studies on the important role of depression, anxiety and subjec-
tive sleep quality in the experience of fatigue. Considerably less
research is available on other psychological factors, such as
social support, stress, self-efficacy, beliefs and behaviours.
Promising evidence is available on the contribution of illness
beliefs and behaviours to the experience of fatigue and there is
some indication that these factors may vary according to treat-
ment modality, reflecting the differential burdens and coping
necessities associated with each treatment modality. Prolonged
perception of the illness as a threat may lead patients to feeling
burnt out, but this held only among CAPD, but not HD patients
[95]. Differential burdens and challenges imposed by each treat-
ment modality may explain why illness beliefs and fatigue lev-
els vary. In fact, a recent study found that self-care HD patients
have significantly greater personal control and illness coher-
ence beliefs compared with in-centre patients [102]. There was
also evidence for the role of stress and worrying in fatigue, sug-
gesting that any additional burden, emotional or physical, may
have detrimental effects on energy levels. Poorer illness knowl-
edge may indirectly contribute to vitality via treatment non-
adherence and greater illness-related distress.
Across studies, when cognitive-behavioural and psychological
factors were introduced into the models, many demographic and
clinical factors ceased to be significant, with cognitive-
behavioural and psychological factors explaining 14.6–46% of
unique fatigue/vitality variance [26, 27, 29, 31, 33, 47, 73].
Furthermore, the association between some demographic, social-
situational and clinical factors may be explained by means of
psychological factors. For example, the positive relationship
between age and fatigue has been conventionally explained by
age-related factors like differences in dialysis vintage, physical
functioning and increased comorbidities [3]. However, this age–
fatigue relationship has not been support unanimously across
studies in ESKD [30, 103]. This inconsistency may be explained by
psychological factors, with younger patients possibly perceiving
a greater impact of the illness on their lives and functioning,
therefore holding more severe and maladaptive illness beliefs,
which in turn leading to greater fatigue. Similarly, any link
between marital status and fatigue may be the product of differ-
ences in social support, acting on fatigue indirectly. Employment
status can act as a marker of age and physical activity, but it
simultaneously may be an indication of the perceived role of
patients and can also act as a distraction. In relation to education,
patients with low educational attainment may find it more diffi-
cult to understand their illness and the importance of adhering
to every aspect of treatment, while patients with greater educa-
tional attainment may be more aware of the severity and conse-
quences of the illness. Similarly, some studies have reported a
link between worsening renal function and fatigue in Tx recipi-
ents [29, 104]. A possible explanation may be that for Tx recipi-
ents worsening renal function represents a risk for graft loss,
possibly leading to increased distress, worry and fear [104].
Overall, these findings suggest that the degree of renal function
may not directly impact on energy levels, but rather through
increased distress. Therefore, as Figure 1 postulates, clinical fac-
tors may trigger fatigue, but it is likely to be maintained by psy-
chological processes, leading to a vicious cycle of negative illness
and fatigue beliefs, increased distress and maladaptive behav-
iours. This is based on integrated fatigue models formulated in
other chronic conditions, in particular Chronic Fatigue Syndrome
and multiple sclerosis (MS) [105, 106].
Limitations and future directions
Although there is promising evidence with regards to the role of
psychological factors in the experience of fatigue in this setting,
it is important to emphasize that most of the evidence origi-
nates from cross-sectional studies and therefore, no conclusive
interpretations in relation to causality can be drawn.
Considerably less research is available on psychological factors
in fatigue among transplant recipients and patients in pre-
dialysis care. Corroboration of the evidence for the role of social
support, self-efficacy and illness intrusiveness in fatigue is nec-
essary. Also, longitudinal studies are warranted to provide
causal evidence, particularly for the associations between
depression, anxiety, subjective sleep quality and fatigue. Given
the evidence for differences in illness beliefs depending on RRT,
it would be valuable for future research to compare fatigue-
specific beliefs according to what RRT patients are receiving.
Conclusion
Fatigue is a prevalent and debilitating symptom across the whole
spectrum of renal disease. Previous narrative reviews have mainly
concentrated on fatigue in dialysis patients, indicating at present
a poor understanding of the pathogenesis and risk factors of
fatigue in this patient population. Given the important role psy-
chological and cognitive-behavioural factors have played in cancer
and MS fatigue, this review concentrated exclusively on the cur-
rent evidence for the role of these factors in renal fatigue. The
most consistent evidence emerged with regards to the role of
depression; anxiety and subjective sleep quality in the experience
of fatigue, in many studies the role of these factors was above and
beyond that of demographic, social-situational and clinical fac-
tors. Considerably less research is available on other psychological
constructs, but there are some promising findings on the role of
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illness perceptions and behavioural patterns in the experience of
fatigue. Differences in illness beliefs and behaviours depending on
RRT may also manifest themselves in the experience of fatigue,
reflecting the differential burdens and restrictions of each treat-
ment modality. However, the evidence base consists of single
studies, and corroboration of these findings is warranted, particu-
larly by longitudinal studies. Additionally, the currently available
generic fatigue instruments may be unable to capture the differen-
ces between illness-related fatigue and post-dialysisity-specific
fatigue; therefore, it is unclear what exactly the currently used
fatigue instruments are measuring, possibly contributing to the
incongruities in the literature. Given the modifiable nature of psy-
chological and cognitive-behavioural factors, these can be targeted
in interventions, as has been previously successfully done in other
chronic conditions, in order to alleviate the levels of fatigue in
patients with renal failure.
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